Analysts Set Transcat, Inc. (NASDAQ:TRNS) Price Target at $111.50

Shares of Transcat, Inc. (NASDAQ:TRNSGet Free Report) have been assigned a consensus recommendation of “Hold” from the five analysts that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $111.50.

Several analysts recently weighed in on TRNS shares. HC Wainwright reduced their target price on shares of Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a report on Wednesday, January 29th. Oppenheimer cut shares of Transcat from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 29th. Craig Hallum increased their price target on shares of Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. StockNews.com lowered shares of Transcat from a “hold” rating to a “sell” rating in a research note on Wednesday, February 5th. Finally, Northland Securities reiterated a “market perform” rating and issued a $85.00 price target (down from $110.00) on shares of Transcat in a research note on Wednesday, January 29th.

View Our Latest Report on TRNS

Insider Buying and Selling at Transcat

In related news, Director Craig D. Cairns acquired 1,200 shares of the company’s stock in a transaction dated Friday, January 31st. The stock was bought at an average price of $77.02 per share, with a total value of $92,424.00. Following the purchase, the director now directly owns 1,910 shares in the company, valued at $147,108.20. The trade was a 169.01 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 2.30% of the stock is owned by insiders.

Institutional Trading of Transcat

A number of institutional investors and hedge funds have recently bought and sold shares of TRNS. Jones Financial Companies Lllp increased its stake in Transcat by 686.7% during the 4th quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company’s stock worth $37,000 after buying an additional 309 shares during the period. Aquatic Capital Management LLC lifted its stake in shares of Transcat by 1,052.0% in the fourth quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company’s stock worth $122,000 after acquiring an additional 1,052 shares in the last quarter. Morgan Dempsey Capital Management LLC purchased a new position in Transcat in the fourth quarter valued at about $143,000. SG Americas Securities LLC purchased a new position in Transcat in the fourth quarter valued at about $182,000. Finally, KLP Kapitalforvaltning AS purchased a new position in Transcat in the fourth quarter valued at about $190,000. Institutional investors and hedge funds own 98.34% of the company’s stock.

Transcat Trading Down 1.3 %

NASDAQ TRNS opened at $69.07 on Wednesday. The firm’s 50-day moving average is $82.92 and its two-hundred day moving average is $102.72. Transcat has a 12 month low of $67.56 and a 12 month high of $147.12. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98. The stock has a market capitalization of $642.97 million, a P/E ratio of 37.34 and a beta of 0.66.

Transcat (NASDAQ:TRNSGet Free Report) last issued its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same quarter in the previous year, the firm earned $0.56 EPS. On average, sell-side analysts anticipate that Transcat will post 2.3 earnings per share for the current year.

Transcat Company Profile

(Get Free Report

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Read More

Analyst Recommendations for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.